We build production-grade DTC genetic testing platforms — consumer apps, telehealth-integrated reporting, and multi-state genetic privacy compliance — for consumer genomics companies and clinical labs launching consumer arms.
The market is real. The engineering complexity is harder than most teams budget for. Four failure patterns we see again and again.
HIPAA, GDPR, and the 2026 state genetic privacy patchwork get treated as documentation, not architecture. Rhode Island, South Dakota, Vermont, and 10+ others. By Series B, you rebuild the data layer.
A vendor runs the pipeline, you store the result. Then a regulator asks for analytical validation, a clinician asks how the call was made, a customer asks why their result changed. You cannot answer.
Marketing ships features the lab cannot validate. CAP/CLIA-grade reporting and consumer UX live in two systems with no shared identifier model — creating dangerous inconsistency at scale.
Physician oversight is required in most regulated jurisdictions and increasingly demanded by consumers post-23andMe. Bolt-on integrations break under volume at the worst moments.
We engineer every layer a production DTC genetic testing platform actually needs — compliance architecture, bioinformatics pipeline, clinical reporting, and the consumer experience on top.
Talk to our team →Web and mobile (React, React Native, iOS, Android) — kit purchase, account creation, sample activation, consent capture, report viewing, family accounts, revoke-anywhere consent. SOC 2 + HIPAA-aligned auth.
Order management, shipping integration (USPS, FedEx, Stamps.com, ShipStation), barcode/QR sample binding, return tracking, lab accessioning hand-off, sample failure recovery.
One architectural decision instead of fifty. State-of-residence enforced at consent, data classification by category, foreign-adversary localization controls (15 CFR § 7.4), express research opt-in.
Order authorization, asynchronous physician review, genetic counselor scheduling, result release gated to clinical context. Integrates with Everly Health Solutions, Wheel, or custom.
Reports that meet CAP/CLIA standards on the back end and read like consumer products on the front end. In-app, PDF, and FHIR R4 DiagnosticReport for downstream clinical use.
Every technology choice is deliberate — selected for HIPAA-aligned VPC architecture, clinical-grade reliability, and the ability to scale without rearchitecting.
The 2025 23andMe Chapter 11 filing changed the buyer's question from "how fast can we ship" to "how do we build something customers will still trust in five years."
We design every DTC platform with data portability by default — not because it markets well, but because it is the only architecture that holds up when the regulatory landscape shifts again.
New state laws are absorbed as policy updates, not architectural rebuilds. Our reference architecture treats state-of-residence as a first-class data attribute with policy enforcement at every layer.
The 2026 state privacy patchwork isn't a checkbox. It's a design constraint that needs to live in your data model from day one — not bolted on when regulators come calling.
Most engagements start with a 45-minute Architecture Review where we map your current state against your 2026 compliance and product roadmap, then scope from there.
We map your current state against your 2026 compliance and product roadmap. No pitch — just a clear picture of where you are and what needs to change.
We come back with a realistic scope, timeline, and team composition. Modular or full-stack — you choose the engagement depth that fits your roadmap.
Engineering begins with your compliance architecture as the foundation. Layers are added in priority order, with clear milestones and audit-ready documentation.
Production launch with full observability, incident response playbooks, and a data model that absorbs new state laws without rearchitecting.
Tell us your product roadmap, your test menu, and your compliance footprint. We'll come back with a realistic scope and timeline.
Schedule Your ReviewWe integrate with
Everything you need to know about how we build DTC genomics platforms and what the engagement looks like.
Tell us your product roadmap, your test menu, and your compliance footprint. We'll come back with a realistic scope and timeline.
Bespoke Engineering Studio
Subscribe to our Newsletter
©2026 – ALL RIGHTS RESERVED BY NONSTOP IO TECHNOLOGIES PVT. LTD.
We use cookies to improve your experience and analyze traffic. By clicking “Accept”, you consent to cookies. Privacy Policy